Harbour BioMed Announces IND Clearance for HBM9027 in the U.S. - Thailand PR News - [Banking](https://thailandbusinessnews.net/category/banking/) - [Companies](https://thailandbusinessnews.net/category/companies/) - [Economy](https://thailandbusinessnews.net/category/economy/) - [Press Releases](https://thailandbusinessnews.net/category/press-release/) - [PR Newswire](https://thailandbusinessnews.net/pr-newswire-updates/) - [Tech](https://thailandbusinessnews.net/category/tech/) - [Tourism](https://thailandbusinessnews.net/category/tourism/) - [Press Release](https://thailandbusinessnews.net/category/press-release/) - [Tech](https://thailandbusinessnews.net/category/tech/) # Harbour BioMed Announces IND Clearance for HBM9027 in the U.S. ##### Up next ![Pudong wants expats to settle in. Here's what it offers](https://i0.wp.com/thailandbusinessnews.net/wp-content/uploads/2023/10/AZ-Asia-Pacific-partners-with-Green-Radar-to-enhance-its-email.jpeg?resize=200%2C110&ssl=1 "Pudong wants expats to settle in. Here's what it offers") [](https://thailandbusinessnews.net/press-release/pudong-wants-expats-to-settle-in-heres-what-it-offers/) ###### [Pudong wants expats to settle in. Here's what it offers](https://thailandbusinessnews.net/press-release/pudong-wants-expats-to-settle-in-heres-what-it-offers/) Published on 24 January 2024 ##### Author ##### [ CISION PRNewswire ](https://thailandbusinessnews.net/author/cision/) ##### Tags - [PRNewswire](https://thailandbusinessnews.net/tag/prnewswire/) CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SUZHOU, China, Jan. 24, 2024 /PRNewswire/ — Harbour BioMed (the "Company", HKEX: 02142) announced that the Company has been granted the clearance of Investigational New Drug (IND) from the Food and Drug Administration (FDA) of the United States to initiate the first-in-human (FIH) clinical trial in the U.S. for bispecific antibody HBM9027. This is a phase I study to evaluate the safety, tolerability, pharmacokinetics, and anti-tumor activity of HBM9027 in subjects with advanced solid tumors. HBM9027 is generated from Harbour BioMed’s proprietary fully human HBICE® platform. It is a novel PD-L1xCD40 bispecific antibody, which is designed to activate CD40 relied on PD-L1 crosslinking for a promising safety profile. PD-L1 is overexpressed on a variety of solid malignancies, and with its crosslinking dependent specificity on tumors and potent immune modulation activity, HBM9027 has shown excellent and promising safety profile with strong anti-tumor efficacy in its pre-clinical studies. "HBM9027, developed through our proprietary HBICE® platform, has demonstrated a promising safety profile and robust anti-tumor efficacy," said Dr. Jingsong Wang, Founder, Chairman and CEO of Harbour BioMed. "This achievement highlights the capability of our technology platform in developing novel solutions for advanced solid tumors. We firmly believe that our unweaving commitment to innovation will bring about meaningful advancements in cancer treatment." About HBM9027 HBM9027 is a novel PD-L1xCD40 bispecific antibody, developed using the HBICE® bispecific technology and Harbour Mice® Platform. The development of PD-L1xCD40 bispecific HBICE® further expands the Company’s bispecific immune cell engager into the cutting-edge DC/myeloid cell engager field and demonstrates HBICE® platform’s versatile geometry formats and plug-and-play advantages. About Harbour BioMed Harbour BioMed (HKEX: 02142) is a global biopharmaceutical company committed to the discovery, development, and commercialization of novel antibody therapeutics focusing on immunology and oncology. The Company is building its robust portfolio and differentiated pipeline through internal R&D capability, collaborations with co-discovery and co-development partners, and select acquisitions. The Company’s proprietary antibody technology platforms Harbour Mice® generate fully human monoclonal antibodies in two heavy and two light chain (H2L2) format, as well as heavy chain only (HCAb) format. Building upon the HCAb antibodies, the HCAb-based immune cell engagers (HBICE®) are capable of delivering tumor-killing effects unachievable by traditional combination therapies. Integrating Harbour Mice®, HBICE® with single B cell cloning platform, the antibody discovery engine is highly unique and efficient for the development of next-generation therapeutic antibodies. For more information, please visit [www.harbourbiomed.com](http://www.harbourbiomed.com/). [Source link ](https://www.prnasia.com/story/archive/4319591_CN19591_0?rand=89749) ``` This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network ``` ##### You May Also Like [](https://thailandbusinessnews.net/press-release/superx-and-mercuria-asia-forge-strategic-partnership-to-build-innovative-ai-infrastructure-ecosystem/) ## SuperX and Mercuria Asia Forge Strategic Partnership to Build Innovative AI Infrastructure Ecosystem SINGAPORE, July 22, 2026 /PRNewswire/ — SuperX AI Technology Limited (NASDAQ: SUPX, hereinafter… - [CISION PRNewswire](https://thailandbusinessnews.net/author/cision/ "View all posts by CISION PRNewswire") - July 22, 2026 [](https://thailandbusinessnews.net/press-release/the-baseus-nomos-series-a-revolutionary-step-in-adaptable-convenient-and-superior-fast-charging-technology/) ![The Baseus Nomos Series: A Revolutionary Step in Adaptable, Convenient, and Superior Fast-Charging Technology](https://i0.wp.com/thailandbusinessnews.net/wp-content/uploads/2024/10/Baseus_Nomos_series_High_end_all_in_one_charging_series.jpg?resize=260%2C140&ssl=1 "The Baseus Nomos Series: A Revolutionary Step in Adaptable, Convenient, and Superior Fast-Charging Technology") - [Press Release](https://thailandbusinessnews.net/category/press-release/) - [Tech](https://thailandbusinessnews.net/category/tech/) ## The Baseus Nomos Series: A Revolutionary Step in Adaptable, Convenient, and Superior Fast-Charging Technology NEW YORK, Oct. 24, 2024 /PRNewswire/ — Baseus is a global leader… - [CISION PRNewswire](https://thailandbusinessnews.net/author/cision/ "View all posts by CISION PRNewswire") - October 24, 2024 [](https://thailandbusinessnews.net/press-release/cites-praises-indias-vantara-for-exemplary-wildlife-care-and-full-compliance-with-global-standards/) ![CITES Praises India's Vantara for Exemplary Wildlife Care and Full Compliance with Global Standards](https://i0.wp.com/thailandbusinessnews.net/wp-content/uploads/2025/11/CITES_Photo_1.jpg?resize=260%2C140&ssl=1 "CITES Praises India's Vantara for Exemplary Wildlife Care and Full Compliance with Global Standards") - [Press Release](https://thailandbusinessnews.net/category/press-release/) ## CITES Praises India's Vantara for Exemplary Wildlife Care and Full Compliance with Global Standards DUBAI, UAE, Nov. 13, 2025 /PRNewswire/ — In a significant acknowledgment for… - [CISION PRNewswire](https://thailandbusinessnews.net/author/cision/ "View all posts by CISION PRNewswire") - November 13, 2025 ##### Most Read - [![DBS Hong Kong Partners with Visa, Preface to empower Customers with AI Readiness skills, for the Future of Intelligent Payments](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/dbs-hong-kong-partners-with-visa-preface-to-empower-customers-with-ai-readiness-skills-for-the-future-of-intelligent-payments/ "DBS Hong Kong Partners with Visa, Preface to empower Customers with AI Readiness skills, for the Future of Intelligent Payments") [DBS Hong Kong Partners with Visa, Preface to empower Customers with AI Readiness skills, for the Future of Intelligent Payments](https://thailandbusinessnews.net/press-release/dbs-hong-kong-partners-with-visa-preface-to-empower-customers-with-ai-readiness-skills-for-the-future-of-intelligent-payments/ "DBS Hong Kong Partners with Visa, Preface to empower Customers with AI Readiness skills, for the Future of Intelligent Payments") - [![Piramal Pharma Limited Completes Acquisition of Controlling Stake in Yapan Bio Private Limited](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/piramal-pharma-limited-completes-acquisition-of-controlling-stake-in-yapan-bio-private-limited/ "Piramal Pharma Limited Completes Acquisition of Controlling Stake in Yapan Bio Private Limited") [Piramal Pharma Limited Completes Acquisition of Controlling Stake in Yapan Bio Private Limited](https://thailandbusinessnews.net/press-release/piramal-pharma-limited-completes-acquisition-of-controlling-stake-in-yapan-bio-private-limited/ "Piramal Pharma Limited Completes Acquisition of Controlling Stake in Yapan Bio Private Limited") - [![ZTO Reports Second Quarter 2026 Unaudited Financial Results](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/zto-reports-second-quarter-2026-unaudited-financial-results/ "ZTO Reports Second Quarter 2026 Unaudited Financial Results") [ZTO Reports Second Quarter 2026 Unaudited Financial Results](https://thailandbusinessnews.net/press-release/zto-reports-second-quarter-2026-unaudited-financial-results/ "ZTO Reports Second Quarter 2026 Unaudited Financial Results") - [![Everest Medicines Announces Interim Results for First Half of 2026](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/everest-medicines-announces-interim-results-for-first-half-of-2026/ "Everest Medicines Announces Interim Results for First Half of 2026") [Everest Medicines Announces Interim Results for First Half of 2026](https://thailandbusinessnews.net/press-release/everest-medicines-announces-interim-results-for-first-half-of-2026/ "Everest Medicines Announces Interim Results for First Half of 2026") - [![GSK's Blenrep (belantamab mafodotin) combinations approved in Singapore for treatment of relapsed/refractory multiple myeloma](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/gsks-blenrep-belantamab-mafodotin-combinations-approved-in-singapore-for-treatment-of-relapsed-refractory-multiple-myeloma/ "GSK's Blenrep (belantamab mafodotin) combinations approved in Singapore for treatment of relapsed/refractory multiple myeloma") [GSK's Blenrep (belantamab mafodotin) combinations approved in Singapore for treatment of relapsed/refractory multiple myeloma](https://thailandbusinessnews.net/press-release/gsks-blenrep-belantamab-mafodotin-combinations-approved-in-singapore-for-treatment-of-relapsed-refractory-multiple-myeloma/ "GSK's Blenrep (belantamab mafodotin) combinations approved in Singapore for treatment of relapsed/refractory multiple myeloma") - [![QNET Unveils New Leadership Team to Accelerate Growth and Shape the Future of Direct Selling](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/qnet-unveils-new-leadership-team-to-accelerate-growth-and-shape-the-future-of-direct-selling/ "QNET Unveils New Leadership Team to Accelerate Growth and Shape the Future of Direct Selling") [QNET Unveils New Leadership Team to Accelerate Growth and Shape the Future of Direct Selling](https://thailandbusinessnews.net/press-release/qnet-unveils-new-leadership-team-to-accelerate-growth-and-shape-the-future-of-direct-selling/ "QNET Unveils New Leadership Team to Accelerate Growth and Shape the Future of Direct Selling") ##### Subscribe via Email Enter your email address to subscribe and receive notifications of new posts by email. Email Address Subscribe [](https://thailandbusinessnews.net/press-release/xiao-i-corporation-announces-plan-to-implement-ads-ratio-change-3/) ## Xiao-I Corporation Announces Plan to Implement ADS Ratio Change SHANGHAI, Aug. 20, 2026 /PRNewswire/ — Xiao-I Corporation ("Xiao-I" or… [](https://thailandbusinessnews.net/press-release/dcai-and-corti-launch-sovereign-ai-control-layer-for-european-enterprises-trifork-first-to-adopt-as-implementation-partner/) ## DCAI and Corti Launch Sovereign AI Control Layer for European Enterprises – Trifork First to Adopt as Implementation Partner New platform combines Europe’s sovereign AI infrastructure with healthcare-grade… [](https://thailandbusinessnews.net/press-release/bybit-launches-ai-future-city-campaign-connecting-ai-market-themes-with-tradfi-perpetuals/) ![Bybit Launches AI Future City Campaign Connecting AI Market Themes With TradFi Perpetuals](https://i0.wp.com/mmx.prnasia.com/media/MS1971655/Bybit-Updated-Logo_18-Aug-2026.jpg?resize=260%2C140&ssl=1 "Bybit Launches AI Future City Campaign Connecting AI Market Themes With TradFi Perpetuals") ## Bybit Launches AI Future City Campaign Connecting AI Market Themes With TradFi Perpetuals DUBAI, UAE, Aug. 20, 2026 /PRNewswire/ — Bybit, the world’s… [](https://thailandbusinessnews.net/press-release/sands-china-wins-two-pata-gold-awards/) ![Sands China Wins Two PATA Gold Awards](https://i0.wp.com/mmx.prnasia.com/media/MS1973022/20260820060504EDT_image_5.jpg?resize=260%2C140&ssl=1 "Sands China Wins Two PATA Gold Awards") ## Sands China Wins Two PATA Gold Awards The company’s social inclusion and cultural publishing initiatives garner…